Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 197.01

-2.9%

Dec 1 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Cheryl Galt who wrote (26022)	10/7/1998 10:55:00 AM
From: bob zagorin	Read Replies (1) of 32384

from Medscape. <http://www.medscape.com/Medscape/public/MP/98/1002.html#08> - Breast Cancer Care: Developments in 1998 ---------------------------------------------------------- Tamoxifen and raloxifene for prevention, sentinel node mapping for staging, and anti-HER-2/neu monoclonal antibody for treatment help drive down the morbidity and mortality associated with breast cancer and its treatment. [Cancer Control: JMCC 5(4):338-345, 1998]

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next